Rare lymphomas in routine practice – Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms

por Knauf, Wolfgang, Abenhardt, Wolfgang, Koenigsmann, Michael, Maintz, Christoph, Sandner, Reiner, Zahn, Mark‐Oliver, Schnell, Roland, Tech, Susanne, Kaiser‐Osterhues, Anja, Houet, Leonora, Marschner, Norbert
Publicado 2021

Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study

por Jakob, Andreas, Zahn, Mark-Oliver, Nusch, Arnd, Werner, Thorsten, Schnell, Roland, Frank, Melanie, Hamm, Nicole, Däßler, Klaus-Ulrich, Losem, Christoph, Welslau, Manfred, Hoevel, Petra, Potthoff, Karin
Publicado 2022

Health status and infections in patients with symptomatic primary and secondary immunoglobulin G (IgG) deficiencies receiving intravenous IgG replacement

por Weide, Rudolf, Schnell, Roland, Schardt, Christof, Koenigsmann, Michael, Otremba, Burkhard, Zahn, Mark-Oliver, Wierecky, Jan, Braun, Ute, Hensel, Manfred, Klausmann, Martine, Fleckenstein, Doris, Ehscheidt, Peter, Feiten, Stefan
Publicado 2020

ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability

por Scheffler, Matthias, Schultheis, Anne, Teixido, Cristina, Michels, Sebastian, Morales-Espinosa, Daniela, Viteri, Santiago, Hartmann, Wolfgang, Merkelbach-Bruse, Sabine, Fischer, Rieke, Schildhaus, Hans-Ulrich, Fassunke, Jana, Sebastian, Martin, Serke, Monika, Kaminsky, Britta, Randerath, Winfried, Gerigk, Ulrich, Ko, Yon-Dschun, Krüger, Stefan, Schnell, Roland, Rothe, Achim, Kropf-Sanchen, Cornelia, Heukamp, Lukas, Rosell, Rafael, Büttner, Reinhard, Wolf, Jürgen
Publicado 2015

Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer

por Schildhaus, Hans-Ulrich, Heukamp, Lukas C, Merkelbach-Bruse, Sabine, Riesner, Katharina, Schmitz, Katja, Binot, Elke, Paggen, Ellen, Albus, Kerstin, Schulte, Wolfgang, Ko, Yon-Dschun, Schlesinger, Andreas, Ansén, Sascha, Engel-Riedel, Walburga, Brockmann, Michael, Serke, Monika, Gerigk, Ulrich, Huss, Sebastian, Göke, Friederike, Perner, Sven, Hekmat, Khosro, Frank, Konrad F, Reiser, Marcel, Schnell, Roland, Bos, Marc, Mattonet, Christian, Sos, Martin, Stoelben, Erich, Wolf, Jürgen, Zander, Thomas, Buettner, Reinhard
Publicado 2012

Sorafenib and everolimus in patients with advanced solid tumors and KRAS‐mutated NSCLC: A phase I trial with early pharmacodynamic FDG‐PET assessment

por Nogova, Lucia, Mattonet, Christian, Scheffler, Matthias, Taubert, Max, Gardizi, Masyar, Sos, Martin L., Michels, Sebastian, Fischer, Rieke N., Limburg, Meike, Abdulla, Diana S.Y., Persigehl, Thorsten, Kobe, Carsten, Merkelbach‐Bruse, Sabine, Franklin, Jeremy, Backes, Heiko, Schnell, Roland, Behringer, Dirk, Kaminsky, Britta, Eichstaedt, Martina, Stelzer, Christoph, Kinzig, Martina, Sörgel, Fritz, Tian, Yingying, Junge, Lisa, Suleiman, Ahmed A., Frechen, Sebastian, Rokitta, Dennis, Ouyang, Dongsheng, Fuhr, Uwe, Buettner, Reinhard, Wolf, Jürgen
Publicado 2020